Middle East News Center: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Center.

Press releases published on September 8, 2026

Sep. 8, 2026

NeOnc' Phase 2 Data Could Put Cancer on the Ropes

Indeterminate GlobeNewswire

Sep. 8, 2026

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

Indeterminate GlobeNewswire

Sep. 8, 2026

Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome

Indeterminate GlobeNewswire

Sep. 8, 2026

Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks

Indeterminate GlobeNewswire

Sep. 8, 2026

Greenland Mines Enters New Era as Rare Earths and Critical Minerals Company, Achieves Full Nasdaq Compliance and Sets Biotech Spin-Off for Q4

Indeterminate GlobeNewswire

Sep. 8, 2026

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

Indeterminate GlobeNewswire

Sep. 8, 2026

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Indeterminate GlobeNewswire

Sep. 8, 2026

Funded Trader Markets Opens Four-Platform Access With Swap-Free Accounts and Up to 90% Profit Share

Indeterminate GlobeNewswire

Sep. 8, 2026

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Maxus Mining Expands Hurley West Antimony Project to Cover Historic Stibnite Prospect with Historical Results up to 16.9% Sb

Indeterminate GlobeNewswire

Sep. 8, 2026

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

Sep. 8, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

Sep. 8, 2026

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

Sep. 8, 2026

Swvl Expands HSBC Working Capital Facility by 110% to an aggregate of $1.4 million and Deepens Relationship Through HSBC Global Payment Solutions

Indeterminate GlobeNewswire

Sep. 8, 2026

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire